An unusual case of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia presenting with intractable seizures and interference with automated testing

Swerdlow SH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H (2017) Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. International Agency for Research on Cancer, Lyon, pp 232–234

Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005) Diagnosis and management of Waldenstrom macroglobulinemia. J Clin Oncol 23:1564–1577

Mazzucchelli M, Frustaci AM, Deodato M, Cairoli R, Tedeschi A (2018) Waldenstrom macroglobulinemia: an update. Mediterr J Hematol Infect Dis 10:e2018004

Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR (2012) MYD88 L265P somatic mutation in Waldenstrom macroglobulinemia. N Engl J Med 367:826–833

Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M (2013) Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom macroglobulinemia and related lymphoid neoplasms. Blood 121:2522–2528

Gertz MA (2019) Waldenstrom macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 94:266–276

Fukushima M, Okoshi Y, Fukazawa K, Koshino M, Ishiguro S, Mitsuhashi S, Saitoh H, Iijima T, Kojima H, Hori M (2017) Lymphoplasmacytic lymphoma presenting with diarrhea and joint pain which was successfully diagnosed by an MYD88 mutation analysis. Intern Med 56(7):847–851

Owen RG, Treon SP, Al-Katib A et al (2003) Clinicopathological definition of Waldenstrom macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstr ¨om’s macroglobulinemia. Semin Oncol 30(2):110–115

Swerdlow SH, Campo E, Harris NL, et al, eds (2008) WHO classification of tumours of the haematopoietic and lymphoid tissues. 4th ed. Lyon, France:IARC Press. World Health Organization Classification of Tumours; vol 2

Waldenstorm J (1944) Incipient myelomatosis or ‘essential’ hyperglobulinemia with fibrinogenopenia: a new syndrome? Acta Med Scand 17(3):216–222

Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr (1998) Waldenstrom macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer. 82(6):1078–1081

Herrinton LJ, Weiss NS (1993) Incidence of Waldenstrom macroglobulinemia. Blood. 82(10):3148–3150

Naderi N, Yang DT (2013) MDLymphoplasmacytic lymphoma and Waldenstrom Macroglobulinemia. Arch Pathol Lab Med 137:580–585

Tournilhac O, Santos DD, Xu L, Kutok J, Tai YT, le Gouill S, Catley L, Hunter Z, Branagan AR, Boyce JA, Munshi N, Anderson KC, Treon SP (2006) Mast cells in Waldenstrom macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol 17(8):1275–1282

Bjorkholm M, Johannsson E, Papamichael D et al (2003) Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom macroglobulinemia: a two-institution study. Semin Oncol 30(2):226–230

Aoki H, Takishita M, Kosaka M, Saito S (1995) Frequent somatic mutations in D and/or JH segments of ig gene in Waldenstrom macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter’s syndrome but not in common CLL. Blood. 85(7):1913–1919

Khan TMA, Ansari Y, Siddiqui AH, Ansari SA, Siddiqui F (2019) Development of central nervous system vasculitis in a patient with Waldenstrom macroglobulinemia: a rare presentation with poor prognosis. Cureus. 11(10):e6039

Crawford J, Cox EB, Cohen HJ (1985) Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 79(1):13–22

MacKenzie MR, Lee TK (1977) Blood viscosity in Waldenstrom macroglobulinemia. Blood. 49(4):507–510

García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF, Spanish Group for the Study of Waldenström Macroglobulinaemia and PETHEMA (Programme for the Study and Treatment of Haematological Malignancies) (2001) Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 115:575–582

Dimopoulos MA, Anagnostopoulos A (2005) Waldenström macroglobulinemia. Best Pract Res Clin Haematol 18:747–765. https://doi.org/10.1016/j.beha.2005.01.028

Baehring JM, Hochberg EP, Raje N, Ulrickson M, Hochberg FH (2008) Neurological manifestations of Waldenstrom macroglobulinemia. Nat Clin Pract Neurol 4:547–556

Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D (2015) Cryoglobulinemia vasculitis. Am J Med 128:950–955

Feldman L, Dhamne M, Li Y (2019) Neurologic manifestations associated with cryoglobulinemia: a single center experience. J Neurol Sci 398:121–127

Reik L, Korn JH (1981) Cryoglobulinemia with encephalopathy: successful treatment by plasma exchange. Ann Neurol 10:488–490

Pagano G, Komici K, Femminella GD, de Lucia C, Ianniciello M, Leosco D, Ferrara N, Rengo G (2014) Sudden onset of coma in a 70-year-old woman with cryoglobulinemia. Am J Case Rep 15:56–59

Issa GC, Leblebjian H, Roccaro AM, Ghobrial IM (2011) New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia. Curr Opin Hematol 18(4):260–265